Raymond Ng
Raymond Ng, Raritan, NJ US
Patent application number | Description | Published |
---|---|---|
20090258909 | Novel Benzimidazole Derivatives Useful as Selective Androgen Receptor Modulators (SARMS) - The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. | 10-15-2009 |
20100298383 | NOVEL BENZIMIDAZOLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) - The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. | 11-25-2010 |
20110086883 | NOVEL BENZIMIDAZOLE DERIVATIVES USEFUL AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) - The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. | 04-14-2011 |
Raymond Ng, Farmington Hills, MI US
Patent application number | Description | Published |
---|---|---|
20100218602 | Sender Card Contamination Reduction due to Current Application to Sender Card - Disclosed herein is a system for use in a tank containing a contaminative fluid. The system includes an electrically conductive resistive material in fluid communication with the contents of the tank, a controller configured to periodically generate a control signal, and a variable power supply coupled to the electrically conductive material to provide a current within a normal operating range and to supply current at an elevated level in response to a control signal, wherein the elevated level is selected to heat the electrically conductive material to a temperature sufficient to remove contamination building thereon. | 09-02-2010 |
Raymond Ng, San Ramon, CA US
Patent application number | Description | Published |
---|---|---|
20100081680 | N-SULFONAMIDO POLYCYCLIC PYRAZOLYL COMPOUNDS - The current invention provides compounds having a structure according to Formulae 1, 2, 3, and 4: | 04-01-2010 |
Raymond Ng, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20100046519 | Re-Ordering Segments of a Large Number of Segmented Service Flows - A method and network device for re-ordering segments of a segmented data stream. The method includes receiving at least two segments of a segmented data stream. A descriptor for each of the at least two segments is obtained, and the at least two segments are re-ordered to generate re-ordered segments, where the re-ordered segments are in an original order. A set of re-ordered segments are processed to obtain at least one data packet, where at least one descriptor is utilized in the processing of the set of re-ordered segments. | 02-25-2010 |
20120144244 | SINGLE-EVENT-UPSET CONTROLLER WRAPPER THAT FACILITATES FAULT INJECTION - A method that determines the system impact of single event upset (SEU) and a single event upset (SEU) wrapper that controls a SEU controller is disclosed. The method injects faults into a component (e.g. FPGA, ASIC) of an operational system that is carrying live traffic and monitors the system's response to the faults to determine the impact of SEU on the system. The SEU wrapper sends the SEU controller a pattern scheme that includes information indicating when, where, how often, and/or how long to inject bursts of one or more faults into memory of the component of the system. A burst of faults contains faults that are consecutively injected into the array of memory blocks. After each fault in a burst is injected, one or more errors in one or more memory elements are detected and/or corrected. Information regarding the detection and/or the correction of an error is updated using registers that store counters. After injecting a burst of faults, the SEU controller waits for a predetermined amount of time. While waiting for a predetermined amount of time, the system monitors the system response to the burst of faults, such as monitoring the system for failures. After waiting, the SEU controller determines whether to inject another burst of faults. Bursts of faults are injected into the plurality of memory blocks until a system failure is detected or until the pattern scheme indicates to no longer inject bursts of faults into the memory. | 06-07-2012 |
Raymond Ng, Alpharetta, GA US
Patent application number | Description | Published |
---|---|---|
20080280974 | Spiro compounds for treatment of inflammatory disorders - Provided are compounds, pharmaceutical compositions and methods of treatment or prophylaxis of an inflammatory condition, in particular asthma. The compounds are of the general Formula I, or a pharmaceutically acceptable salt, ester, prodrug or derivative thereof: | 11-13-2008 |
20090270454 | Sulfonamide containing compounds for treatment of inflammatory disorders - Provided are compounds, pharmaceutical compositions and methods of treatment or prophylaxis of an inflammatory condition, in particular asthma. The compounds are of the general Formula I, or a pharmaceutically acceptable salt, ester, prodrug or derivative thereof: | 10-29-2009 |
Raymond Ng, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20110171645 | METHODS OF DIAGNOSING ACUTE CARDIAC ALLOGRAFT REJECTION - The present invention relates to methods of diagnosing acute rejection of a cardiac allograft using genomic expression profiling, proteomic expression profiling, metabolite profiling, or alloreactive T-cell genomic expression profiling, | 07-14-2011 |
20110189680 | Methods of Diagnosing Rejection of a Kidney Allograft Using Genomic or Proteomic Expression Profiling - A method of determining the acute allograft rejection status of a subject, the method comprising the steps of: determining the nucleic acid expression profile of one or more than one nucleic acid markers, or one or more than one proteomic markers in a biological sample from the subject; comparing the expression profile of the one or more than one nucleic acid markers to a control profile; and determining whether the expression level of the one or more than one nucleic acid markers is increased relative to the control profile, wherein the increase of the one or more than one nucleic acid markers is indicative of the acute rejection status of the subject. | 08-04-2011 |
20110190151 | METHODS OF DIAGNOSING CHRONIC CARDIAC ALLOGRAFT REJECTION - The present invention relates to methods of diagnosing chronic rejection of a cardiac allograft using genomic expression profiling, proteomic expression profiling, or a combination of genomic and proteomic expression profiling. | 08-04-2011 |
Raymond Ng, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20140380403 | SECURE ACCESS ENFORCEMENT PROXY - Efficient architecture for a secure access enforcement proxy is described. The proxy interfaces with multiple subsystems and multiple shared resources. The proxy identifies an original transaction command being sent from one of the subsystems to one of the shared resources, identifies a policy corresponding to the subsystem, performs an action pertaining to the original transaction command based on the policy, and sends a response to the subsystem based on the action. | 12-25-2014 |